These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8919570)

  • 1. Cost-effectiveness of screening for colorectal cancer: a simulation model.
    Neilson AR; Whynes DK
    IMA J Math Appl Med Biol; 1995; 12(3-4):355-67. PubMed ID: 8919570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of faecal occult blood screening for colorectal cancer: results of the Nottingham trial.
    Whynes DK
    Crit Rev Oncol Hematol; 1999 Nov; 32(2):155-65. PubMed ID: 10612015
    [No Abstract]   [Full Text] [Related]  

  • 4. A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer.
    Lejeune C; Arveux P; Dancourt V; Fagnani F; Bonithon-Kopp C; Faivre J
    Eur J Cancer Prev; 2003 Feb; 12(1):77-84. PubMed ID: 12548114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the impact of the screening programme for colorectal cancer in the UK.
    Parkin DM; Tappenden P; Olsen AH; Patnick J; Sasieni P
    J Med Screen; 2008; 15(4):163-74. PubMed ID: 19106256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal occult blood screening for colorectal cancer: is it cost-effective?
    Whynes DK; Neilson AR; Walker AR; Hardcastle JD
    Health Econ; 1998 Feb; 7(1):21-9. PubMed ID: 9541081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-effectiveness analysis on colorectal cancer screening program].
    Huang QC; Ye D; Jiang XY; Li QL; Yao KY; Wang JB; Jin MJ; Chen K
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):65-68. PubMed ID: 28100379
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of CT colonography for UK NHS colorectal cancer screening of asymptomatic adults aged 60-69 years.
    Lee D; Muston D; Sweet A; Cunningham C; Slater A; Lock K
    Appl Health Econ Health Policy; 2010; 8(3):141-54. PubMed ID: 20369905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation model predicts cost savings from colorectal cancer screening.
    Dreyfuss JH
    CA Cancer J Clin; 2010; 60(1):3-5. PubMed ID: 20018975
    [No Abstract]   [Full Text] [Related]  

  • 12. [Surveillance and cost-effectiveness of colonoscopy in asymptomatic increased risk subjects of colorectal cancer: Ferrara experience].
    Matarese V; Pezzoli A; Trevisani L; Boccia S; Brancaleoni M; Simone L; Feo C; Gullini S
    Recenti Prog Med; 2004; 95(7-8):352-7. PubMed ID: 15303544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat colonoscopy every 10 years or single colonoscopy for colorectal neoplasm screening in average-risk Chinese: a cost-effectiveness analysis.
    Wang ZH; Gao QY; Fang JY
    Asian Pac J Cancer Prev; 2012; 13(5):1761-6. PubMed ID: 22901118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening; cost-effective in practice?
    De Koning HJ
    Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and cost effectiveness of a health care provider-directed intervention to promote colorectal cancer screening among Veterans.
    Wolf MS; Fitzner KA; Powell EF; McCaffrey KR; Pickard AS; McKoy JM; Lindenberg J; Schumock GT; Carson KR; Ferreira MR; Dolan NC; Bennett CL
    J Clin Oncol; 2005 Dec; 23(34):8877-83. PubMed ID: 16314648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness studies fan colonoscopy debate.
    Newman L
    J Natl Cancer Inst; 2000 Nov; 92(22):1796-8. PubMed ID: 11078753
    [No Abstract]   [Full Text] [Related]  

  • 17. Critical Analysis of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review.
    Silva-Illanes N; Espinoza M
    Value Health; 2018 Jul; 21(7):858-873. PubMed ID: 30005759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer: too early to be dogmatic.
    Solomon MJ
    Med J Aust; 1996 Jul; 165(2):68-9. PubMed ID: 8692061
    [No Abstract]   [Full Text] [Related]  

  • 19. Markov's modeling for screening strategies for colorectal cancer.
    Barouni M; Larizadeh MH; Sabermahani A; Ghaderi H
    Asian Pac J Cancer Prev; 2012; 13(10):5125-9. PubMed ID: 23244122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of costs and effects of screening for colorectal cancer in the United States.
    Byers T; Gorsky R
    Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.